{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:48:05Z","timestamp":1788468485511,"version":"build-2803163510"},"reference-count":65,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2017.00240","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T04:52:55Z","timestamp":1511153575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":69,"title":["The \u201cEndless Trip\u201d among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review"],"prefix":"10.3389","volume":"8","author":[{"given":"Laura","family":"Orsolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele Duccio","family":"Papanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"De Berardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Guirguis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Martin","family":"Corkery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Schifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"B1","volume-title":"DSM 5. Diagnostic and Statistical Manual of Mental Disorders\u2013\u2013Fifth Version","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0376-8716(02)00306-X","article-title":"Hallucinogen persisting perception disorder: what do we know after 50 years?","volume":"69","author":"Halpern","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"B3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/archpsyc.1983.01790070074009","article-title":"Visual phenomenology of the LSD flashback","volume":"40","author":"Abraham","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1192\/bjp.140.5.518","article-title":"A chronic impairment of color vision in users of LSD","volume":"140","author":"Abraham","year":"1982","journal-title":"Br J Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0925-4927(01)00098-1","article-title":"EEG coherence in post-LSD visual hallucinations","volume":"107","author":"Abraham","year":"2001","journal-title":"Psychiatry Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/00005053-198204000-00006","article-title":"Flashback phenomena. Clinical and diagnostic dilemmas","volume":"170","author":"Alarcon","year":"1982","journal-title":"J Nerv Ment Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00005053-198405000-00004","article-title":"Flashbacks and memory phenomena. A comment on \u201cFlashback phenomena \u2013 clinical and diagnostic dilemmas\u201d","volume":"172","author":"McGee","year":"1984","journal-title":"J Nerv Ment Dis"},{"key":"B8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1192\/bjp.100.419.491","article-title":"The therapeutic value of lysergic acid diethylamide in mental illness","volume":"100","author":"Sandison","year":"1954","journal-title":"J Ment Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1176\/ajp.124.3.393","article-title":"Further observations on untoward reactions to LSD","volume":"124","author":"Robbins","year":"1967","journal-title":"Am J Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1176\/ajp.126.4.565","article-title":"Flashbacks: recurrent intrusive images after the use of LSD","volume":"126","author":"Horowitz","year":"1969","journal-title":"Am J Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/02791072.1970.10471357","article-title":"Analysis of the LSD flashback","volume":"3","author":"Shick","year":"1970","journal-title":"J Psychedel Drugs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00343238","article-title":"Flashbacks: a personal follow-up","volume":"222","author":"Holsten","year":"1976","journal-title":"Arch Psychiatr Nervenkr"},{"key":"B13","volume-title":"DSM III-R. Diagnostic and Statistical Manual of Mental Disorders\u2013\u2013Third Revised Version","year":"1987"},{"key":"B14","volume-title":"DSM IV-TR. Diagnostic and Statistical Manual of Mental Disorders\u2013\u2013Forth Text Revised Version","year":"2000"},{"key":"B15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1037\/a0027766","article-title":"The structure of diagnostic and statistical manual of mental disorders (4th edn) personality disorder symptoms in a large national sample","volume":"3","author":"Trull","year":"2012","journal-title":"Personal Disord"},{"key":"B16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1037\/0021-843X.97.4.443","article-title":"Visual function in past users of LSD: psychophysical findings","volume":"97","author":"Abraham","year":"1988","journal-title":"J Abnorm Psychol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1098\/rstb.1977.0050","article-title":"Plasticity of ocular dominance columns in monkey striate cortex","volume":"278","author":"Hubel","year":"1977","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eurpsy.2005.04.008","article-title":"Hallucinogen persisting perception disorder after psilocybin consumption: a case study","volume":"20","author":"Espiard","year":"2005","journal-title":"Eur Psychiatry"},{"key":"B19","first-page":"277","article-title":"Synthetic cannabis substances (SPS) use and hallucinogen persisting perception disorder (HPPD): two case reports","volume":"51","author":"Lerner","year":"2014","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2017.1316431","article-title":"JWH-122 consumption adverse effects: a case of hallucinogen persisting perception disorder five-year follow-up","volume":"25","author":"Coppola","year":"2017","journal-title":"J Psychoactive Drugs"},{"key":"B21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00004714-199606000-00008","article-title":"LSD-like panic from risperidone in post-LSD visual disorder","volume":"16","author":"Abraham","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1176\/ajp.154.3.437a","article-title":"Naltrexone treatment of hallucinogen persisting perception disorder","volume":"154","author":"Lerner","year":"1997","journal-title":"Am J Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4088\/JCP.v58n0206a","article-title":"Sertraline treatment of hallucinogen persisting perception disorder","volume":"58","author":"Young","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00004850-200015010-00005","article-title":"LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study","volume":"15","author":"Lerner","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"B25","first-page":"133","article-title":"LSD-induced hallucinogen persisting perception disorder treated with clonazepam: two case reports","volume":"38","author":"Lerner","year":"2001","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"B26","first-page":"100","article-title":"LSD-induced hallucinogen persisting perception disorder with depressive features treated with reboxetine: case report","volume":"39","author":"Lerner","year":"2002","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00004850-200303000-00007","article-title":"Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features","volume":"18","author":"Lerner","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/2045125312451270","article-title":"Hallucinogen-persisting perception disorder","volume":"2","author":"Hermle","year":"2012","journal-title":"Ther Adv Psychopharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4172\/1000121","article-title":"Hallucinogen persisting perception disorder (HPPD) and flashback are they identical?","volume":"1","author":"Hermle","year":"2013","journal-title":"J Alcohol Drug Depend"},{"key":"B30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1017\/ipm.2013.59","article-title":"Improvement of hallucinogen persisting perception disorder (HPPD) with oral risperidone: case report","volume":"31","author":"Subramanian","year":"2013","journal-title":"Ir J Psychol Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/0897190014566314","article-title":"Hallucinogen persisting perception disorder and risk of suicide","volume":"29","author":"Brodrick","year":"2016","journal-title":"J Pharm Pract"},{"key":"B32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/14659890903271624","article-title":"User perceptions of the benefits and harms of hallucinogenic drug use: a web-based questionnaire study","volume":"15","author":"Carhart-Harris","year":"2010","journal-title":"J Subst Use"},{"key":"B33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugalcdep.2010.09.006","article-title":"Abnormal visual experiences in individuals with histories of hallucinogen use: a web-based questionnaire","volume":"114","author":"Baggott","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"B34","first-page":"307","article-title":"LSD flashbacks\u2014the appearance of new visual imagery not experienced during initial intoxication: two case reports","volume":"51","author":"Lerner","year":"2014","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/15504263.2014.906155","article-title":"Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation","volume":"10","author":"Lev-Ran","year":"2014","journal-title":"J Dual Diagn"},{"key":"B36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10633-015-9481-2","article-title":"Ophthalmological assessment of cannabis-induced persisting perception disorder: is there a direct retinal effect?","volume":"130","author":"Zobor","year":"2015","journal-title":"Doc Ophthalmol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/ajad.12204","article-title":"Schizophrenia and hallucinogen persisting perception disorder: a clinical investigation","volume":"24","author":"Lev-Ran","year":"2015","journal-title":"Am J Addict"},{"key":"B38","first-page":"67","article-title":"LSD-associated \u201cAlice in Wonderland Syndrome\u201d(AIWS): a hallucinogen persisting perception disorder (HPPD) case report","volume":"52","author":"Lerner","year":"2015","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2016_457","article-title":"A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD","volume-title":"Current Topics in Behavioral Neurosciences","author":"Halpern","year":"2016"},{"key":"B40","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/ajad.12577","article-title":"Comparing triggers to visual disturbances among individuals with positive vs. negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use","volume":"26","author":"Lev-Ran","year":"2017","journal-title":"Am J Addict"},{"key":"B41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0893-133X(95)00136-2","article-title":"The psychopharmacology of hallucinogens","volume":"14","author":"Abraham","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1360-0443.1973.tb01263.x","article-title":"Adverse reactions and recurrences from marihuana use","volume":"68","author":"Annis","year":"1973","journal-title":"Br J Addict Alcohol Other Drugs"},{"key":"B44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1055\/s-2003-38173","article-title":"Persisting visual hallucinations and illusions in previously drug-addicted patients","volume":"220","author":"Gaillard","year":"2003","journal-title":"Klin Monbl Augenheilkd"},{"key":"B45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1192\/bjp.159.5.713","article-title":"\u2018Ecstasy\u2019 psychosis and flashbacks","volume":"159","author":"Creighton","year":"1991","journal-title":"Br J Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1192\/bjp.160.2.276a","article-title":"Flashbacks following MDMA","volume":"160","author":"McGuire","year":"1992","journal-title":"Br J Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1192\/bjp.165.3.391","article-title":"Diversity of psychopathology associated with use of 3,4- methylenedioxymethamphetamine (\u2018Ecstasy\u2019)","volume":"165","author":"McGuire","year":"1994","journal-title":"Br J Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1586\/17512433.2016.1167597","article-title":"Novel psychoactive substances: the pharmacology of stimulants and hallucinogens","volume":"9","author":"Schifano","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B50","volume-title":"ICD-10. International Statistical Classification of Diseases and Related Health Problems 10th Revision","year":"1992"},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Book Series","author":"Higgins","year":"2008"},{"key":"B52","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0140-6736(55)91156-9","article-title":"Hallucinogenic drugs","volume":"268","author":"Cooper","year":"1955","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.biopsych.2005.06.038","article-title":"Psychological and cognitive effects of long-term peyote use among Native Americans","volume":"58","author":"Halpern","year":"2005","journal-title":"Biol Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJM197004302821803","article-title":"Adverse reactions to marihuana. Classification and suggested treatment","volume":"282","author":"Weil","year":"1970","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00005053-198410000-00001","article-title":"Adverse reactions to psychedelic drugs. A review of the literature","volume":"172","author":"Strassman","year":"1984","journal-title":"J Nerv Ment Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1300\/J069v18n02_06","article-title":"LSD use and flashbacks in alcoholic patients","volume":"18","author":"Batzer","year":"1999","journal-title":"J Addict Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hup.2312","article-title":"\u2018Spiceophrenia\u2019: a systematic overview of \u2018spice\u2019\u2014related psychopathological issues and a case report","volume":"28","author":"Papanti","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1108\/ADD-02-2014-0006","article-title":"\u2018Noids\u2019 in a nutshell: everything you (don\u2019t) want to know about synthetic cannabimimetics","volume":"7","author":"Papanti","year":"2014","journal-title":"Adv Dual Diagn"},{"key":"B60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.psym.2011.01.004","article-title":"Psychiatric sequelae of spice, K2, and synthetic cannabinoid receptor agonists","volume":"52","author":"Benford","year":"2011","journal-title":"Psychosomatics"},{"key":"B61","first-page":"25","article-title":"Benign and time-limited visual disturbances (flashbacks) in recent abstinent high-potency heavy smokers","volume":"48","author":"Lerner","year":"2011","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/14740338.2016.1201475","article-title":"An update of safety of clinically used atypical antipsychotics","volume":"15","author":"Orsolini","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"B63","article-title":"Hallucinogen related disorders","volume-title":"Comprehensive Textbook of Psychiatry","author":"Abraham","year":"2000"},{"key":"B64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0091-3057(00)00201-X","article-title":"Different effects of nabilone and cannabidiol on binocular depth inversion in man","volume":"66","author":"Leweke","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"B65","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130050884","article-title":"Effects of synthetic delta 9- tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man","volume":"142","author":"Leweke","year":"1999","journal-title":"Psychopharmacology"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2017.00240\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T06:15:44Z","timestamp":1570342544000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2017.00240\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":65,"alternative-id":["10.3389\/fpsyt.2017.00240"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2017.00240","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]},"article-number":"240"}}